NCT06762327 2025-01-07Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung CancerNanjing First Hospital, Nanjing Medical UniversityPhase 2 Not yet recruiting20 enrolled